Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeenat Safdar

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Respiratory Medicine|June 23, 2009
Outcome of pulmonary hypertension subjects transitioned from intravenous prostacyclin to oral bosentanZeenat Safdar
Respiratory Medicine|January 29, 2011
Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogsZeenat Safdar
Clinical Drug Investigation|October 7, 2010
Targeted oral therapies in the treatment of pulmonary arterial hypertensionZeenat Safdar
Vascular Health and Risk Management|April 7, 2011
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertensionZeenat Safdar
Texas Heart Institute Journal|August 6, 2013
Pulmonary hypertension: a woman's diseaseZeenat Safdar
Therapeutic Advances in Respiratory Disease|October 13, 2012
Pulmonary arterial hypertension in pregnant womenZeenat Safdar
Methodist Debakey Cardiovascular Journal|July 26, 2021
Chronic Thromboembolic Pulmonary Hypertension Medical ManagementRyan Logue, Zeenat Safdar
Methodist Debakey Cardiovascular Journal|March 15, 2017
Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and MechanismsSarah Medrek, Zeenat Safdar
International Journal of Chronic Obstructive Pulmonary Disease|October 6, 2009
Update on pulmonary hypertension complicating chronic obstructive pulmonary diseaseSoma Jyothula, Zeenat Safdar
Case Reports in Pulmonology|February 22, 2020
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with EpoprostenolShaadi Abughazaleh, Zeenat Safdar
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Respiratory Medicine|June 23, 2009
Outcome of pulmonary hypertension subjects transitioned from intravenous prostacyclin to oral bosentanZeenat Safdar
Respiratory Medicine|January 29, 2011
Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogsZeenat Safdar
Clinical Drug Investigation|October 7, 2010
Targeted oral therapies in the treatment of pulmonary arterial hypertensionZeenat Safdar
Vascular Health and Risk Management|April 7, 2011
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertensionZeenat Safdar
Texas Heart Institute Journal|August 6, 2013
Pulmonary hypertension: a woman's diseaseZeenat Safdar
Therapeutic Advances in Respiratory Disease|October 13, 2012
Pulmonary arterial hypertension in pregnant womenZeenat Safdar
Methodist Debakey Cardiovascular Journal|July 26, 2021
Chronic Thromboembolic Pulmonary Hypertension Medical ManagementRyan Logue, Zeenat Safdar
Methodist Debakey Cardiovascular Journal|March 15, 2017
Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and MechanismsSarah Medrek, Zeenat Safdar
International Journal of Chronic Obstructive Pulmonary Disease|October 6, 2009
Update on pulmonary hypertension complicating chronic obstructive pulmonary diseaseSoma Jyothula, Zeenat Safdar
Case Reports in Pulmonology|February 22, 2020
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with EpoprostenolShaadi Abughazaleh, Zeenat Safdar
Pageof 7